Hair Therapy & Transplantation
Open Access

The Pathophysiology of Diffuse Alopecia and their Innovative Therapies

Rattapon Avram^{* *}Correspondence: Rattapon Avram, Department of Dermatology, University of Vermont, Burlington, USA, Email:

Author info »

Description

Diffuse alopecia, also known as diffuse hair loss, is a condition characterized by widespread thinning or shedding of hair across the entire scalp rather than localized areas. This condition can be distressing for individuals as it affects overall hair density and volume, leading to concerns about appearance and self-esteem. Understanding the underlying causes, clinical features, diagnostic approaches, and treatment options for diffuse alopecia is important for effectively managing this condition and improving patient outcomes.

Pathophysiology and causes

Diffuse alopecia can result from a variety of underlying conditions and factors. The pathophysiology often involves disruptions in the hair growth cycle, particularly affecting the anagen (growth) and telogen (resting) phases. Key causes include:

Telogen effluvium: Telogen effluvium is a common cause of diffuse alopecia, characterized by an increase in the number of hair follicles entering the telogen phase. This can be triggered by various factors such as physical or emotional stress, major illness, surgery, hormonal changes (e.g., postpartum hair loss), nutritional deficiencies, and certain medications. The result is a temporary shedding of hair that typically occurs several months after the triggering event.

Androgenetic alopecia: Androgenetic alopecia, also known as male or female pattern hair loss, can present as diffuse thinning in some individuals, especially women. It is a hereditary condition influenced by androgens (male hormones) and genetic predisposition. In women, it often manifests as diffuse thinning on the crown and top of the scalp, while men may experience more localized thinning.

Anagen effluvium: Anagen effluvium involves the abrupt loss of hair during the anagen phase of the hair cycle. This condition is commonly associated with contact to toxic agents, such as chemotherapy drugs or radiation therapy, which rapidly disrupt hair growth. The hair loss is typically reversible once the offending agent is discontinued.

Nutritional deficiencies: Deficiencies in need nutrients such as iron, zinc, biotin, and vitamins (e.g., vitamin D and B vitamins) can lead to diffuse hair loss. These nutrients are important for maintaining healthy hair growth and follicle function.

Endocrine disorders: Endocrine disorders such as thyroid dysfunction (hypothyroidism or hyperthyroidism) and Polycystic Ovary Syndrome (PCOS) can contribute to diffuse alopecia. These conditions affect hormone levels, which play a significant role in hair growth regulation.

Autoimmune conditions: Autoimmune disorders like Systemic Lupus Erythematosus (SLE) and alopecia areata can cause diffuse hair loss. In alopecia areata, the immune system mistakenly attacks hair follicles, leading to patchy or diffuse hair loss.

Procedures and therapies

The procedures and therapies commonly used for diffuse alopecia.

Platelet-Rich Plasma (PRP) Therapy: In order to promote hair growth, PRP involves injecting the individual concentrated platelets into the scalp.

Low-Level Laser Therapy (LLLT): LLLT uses red light wavelengths to promote hair growth and improve hair density.

Hair transplantation: In cases of significant hair loss, hair transplant surgery may be considered to restore hair density.

Prognosis and patient support

The prognosis for diffuse alopecia varies depending on the underlying cause and the effectiveness of treatment. Telogen effluvium and anagen effluvium often have a good prognosis, with hair regrowth occurring once the triggering factors are addressed or discontinued. Chronic telogen effluvium may require long-term management, but with appropriate treatment, hair density can improve over time.

Androgenetic alopecia is typically a progressive condition, but treatments like minoxidil and finasteride can slow the progression and promote regrowth. Patients with autoimmune or inflammatory causes of diffuse alopecia may experience periods of remission and relapse, necessitating ongoing monitoring and treatment adjustments. Providing psychological support and counseling is important for patients dealing with diffuse alopecia. The visible changes in hair density and volume can significantly impact selfesteem and quality of life. Encouraging open communication, offering reassurance, and addressing cosmetic concerns can help patients cope with the emotional aspects of hair loss.